KRW 20450.0
(0.74%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 477.26 Billion KRW | 7.22% |
2022 | 445.13 Billion KRW | -0.08% |
2021 | 445.49 Billion KRW | 0.44% |
2020 | 443.52 Billion KRW | 12.73% |
2019 | 393.42 Billion KRW | 1.7% |
2018 | 386.84 Billion KRW | 0.46% |
2017 | 385.06 Billion KRW | -6.79% |
2016 | 413.09 Billion KRW | 71.38% |
2015 | 241.03 Billion KRW | 44.12% |
2014 | 167.25 Billion KRW | 132.03% |
2013 | 72.08 Billion KRW | 41.66% |
2012 | 50.88 Billion KRW | -13.29% |
2011 | 58.68 Billion KRW | -45.29% |
2010 | 107.25 Billion KRW | 24.2% |
2009 | 86.35 Billion KRW | -25.73% |
2008 | 116.27 Billion KRW | 265.99% |
2007 | 31.77 Billion KRW | 55.21% |
2006 | 20.47 Billion KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 512.9 Billion KRW | 7.47% |
2024 Q2 | 555.72 Billion KRW | 8.35% |
2023 Q3 | 420.34 Billion KRW | 1.57% |
2023 FY | 477.26 Billion KRW | 7.22% |
2023 Q1 | 442.69 Billion KRW | -0.55% |
2023 Q2 | 413.84 Billion KRW | -6.52% |
2023 Q4 | 477.26 Billion KRW | 13.54% |
2022 Q4 | 445.13 Billion KRW | -0.23% |
2022 Q1 | 444.08 Billion KRW | -0.32% |
2022 Q2 | 443.63 Billion KRW | -0.1% |
2022 FY | 445.13 Billion KRW | -0.08% |
2022 Q3 | 446.17 Billion KRW | 0.57% |
2021 Q2 | 442.81 Billion KRW | -0.15% |
2021 Q1 | 443.5 Billion KRW | -0.0% |
2021 Q3 | 445.11 Billion KRW | 0.52% |
2021 Q4 | 445.49 Billion KRW | 0.09% |
2021 FY | 445.49 Billion KRW | 0.44% |
2020 Q3 | 442.82 Billion KRW | 12.89% |
2020 FY | 443.52 Billion KRW | 12.73% |
2020 Q2 | 392.27 Billion KRW | -0.35% |
2020 Q1 | 393.65 Billion KRW | 0.06% |
2020 Q4 | 443.52 Billion KRW | 0.16% |
2019 Q1 | 390.89 Billion KRW | 1.05% |
2019 Q2 | 393.36 Billion KRW | 0.63% |
2019 Q4 | 393.42 Billion KRW | 0.19% |
2019 Q3 | 392.66 Billion KRW | -0.18% |
2019 FY | 393.42 Billion KRW | 1.7% |
2018 FY | 386.84 Billion KRW | 0.46% |
2018 Q4 | 386.84 Billion KRW | -2.51% |
2018 Q3 | 396.79 Billion KRW | 0.71% |
2018 Q2 | 393.98 Billion KRW | 1.7% |
2018 Q1 | 387.38 Billion KRW | 0.6% |
2017 FY | 385.06 Billion KRW | -6.79% |
2017 Q2 | 407.23 Billion KRW | -0.81% |
2017 Q3 | 405.12 Billion KRW | -0.52% |
2017 Q4 | 385.06 Billion KRW | -4.95% |
2017 Q1 | 410.55 Billion KRW | -0.62% |
2016 Q2 | 338.26 Billion KRW | 42.28% |
2016 Q4 | 413.09 Billion KRW | 15.27% |
2016 Q3 | 358.36 Billion KRW | 5.94% |
2016 FY | 413.09 Billion KRW | 71.38% |
2016 Q1 | 237.73 Billion KRW | -1.37% |
2015 Q4 | 241.03 Billion KRW | -5.77% |
2015 FY | 241.03 Billion KRW | 44.12% |
2015 Q1 | 162.86 Billion KRW | -2.62% |
2015 Q2 | 167.54 Billion KRW | 2.87% |
2015 Q3 | 255.8 Billion KRW | 52.68% |
2014 Q4 | 167.25 Billion KRW | 147.58% |
2014 Q3 | 67.55 Billion KRW | 2.26% |
2014 Q2 | 66.05 Billion KRW | 0.62% |
2014 FY | 167.25 Billion KRW | 132.03% |
2014 Q1 | 65.65 Billion KRW | -8.92% |
2013 Q1 | 45.75 Billion KRW | -10.08% |
2013 Q3 | 32.04 Billion KRW | -9.38% |
2013 Q4 | 72.08 Billion KRW | 124.94% |
2013 FY | 72.08 Billion KRW | 41.66% |
2013 Q2 | 35.36 Billion KRW | -22.71% |
2012 Q4 | 50.88 Billion KRW | 0.0% |
2012 FY | 50.88 Billion KRW | -13.29% |
2012 Q1 | - KRW | 0.0% |
2011 FY | 58.68 Billion KRW | -45.29% |
2011 Q1 | - KRW | 0.0% |
2011 Q3 | - KRW | 0.0% |
2011 Q2 | - KRW | 0.0% |
2010 FY | 107.25 Billion KRW | 24.2% |
2010 Q2 | - KRW | 0.0% |
2010 Q3 | - KRW | 0.0% |
2009 Q2 | - KRW | 0.0% |
2009 Q3 | - KRW | 0.0% |
2009 Q4 | - KRW | 0.0% |
2009 FY | 86.35 Billion KRW | -25.73% |
2008 Q2 | - KRW | 0.0% |
2008 Q4 | - KRW | 0.0% |
2008 Q3 | - KRW | 0.0% |
2008 FY | 116.27 Billion KRW | 265.99% |
2007 Q4 | - KRW | 0.0% |
2007 Q2 | - KRW | 0.0% |
2007 FY | 31.77 Billion KRW | 55.21% |
2007 Q3 | - KRW | 0.0% |
2006 FY | 20.47 Billion KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
PharmGen Science, Inc. | 37.96 Billion KRW | -1157.16% |
Wooridul Huebrain Limited | 3.35 Billion KRW | -14131.001% |